Latest papers

Guidelines for the welfare and use of animals in cancer research.

Patient-tailored therapy in rheumatoid arthritis: an editorial review.

Molecular biomarkers: a US FDA effort.

Biomarkers in Barrett's oesophagus.

Advances in pharmacogenomics technologies.

Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.

Biomarkers - SMi's Third Summit: discovery, validation & qualification.

The application of biomarkers in clinical trials for motor neuron disease.

Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines.

Antigen-specific immunotherapy against allergic rhinitis: the state of the art.

Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.

Biomarkers in bronchopulmonary cancer.

The Japanese toxicogenomics project: application of toxicogenomics.

Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants.

Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.

Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.

Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib.

Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy?

QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications.

Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series.